This article was originally published in The Tan Sheet
Christopher Bleck to VP, pediatrics at the Abbott Labs division, succeeding Carl Spaulding, who left in May 1998. Bleck joined Abbott in 1983 as a pharmaceutical sales rep, holding several pharmaceutical and international management positions. Most recently, he was divisional VP, president and general manager, Canada
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC